IL-18BP ANTAGONIST ANTIBODIES AND THEIR USE IN MONOTHERAPY AND COMBINATION THERAPY IN THE TREATMENT OF CANCER

The present invention is directed to anti-IL18-BP antibodies and uses thereof. The present invention is directed to monotherapy and combination treatments with for example immune checkpoint inhibitor antibodies, as described herein. La présente invention concerne des anticorps anti-IL18-BP et leurs...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MENA, Assaf, TATIROVSKY, Evgeny, CHIASSON, Alissa, COJOCARU, Gad, SEVER, Iital, ERLICH, Ziv, FRIDMAN-KFIR, Tal, PERPINIAL, Michal, ALTEBER, Zoya, GALPERIN, Moran, OPHIR, Eran, LEIDERMAN, Olga, BLAT, Dan, TILLEMAN, Hadas, TOPORIK, Amir, NIELSON, Nels, NOVIK, Amit, COHEN, Nadav
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention is directed to anti-IL18-BP antibodies and uses thereof. The present invention is directed to monotherapy and combination treatments with for example immune checkpoint inhibitor antibodies, as described herein. La présente invention concerne des anticorps anti-IL18-BP et leurs utilisations. La présente invention concerne des monothérapies et des polythérapies utilisant, par exemple, des anticorps inhibiteurs de point de contrôle immunitaire, tels que décrits dans la description.